Weaver C. Barksdale & Associates’s IBM IBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.19M Sell
8,143
-34
-0.4% -$4.94K 1.26% 48
2017
Q3
$1.13M Hold
8,177
1.27% 47
2017
Q2
$1.2M Buy
8,177
+84
+1% +$12.7K 1.4% 42
2017
Q1
$1.35M Buy
8,093
+1,977
+32% +$332K 1.59% 33
2016
Q4
$971K Sell
6,116
-28
-0.5% -$4.26K 1.56% 29
2016
Q3
$933K Buy
6,144
+632
+11% +$95.9K 1.57% 26
2016
Q2
$800K Hold
5,512
1.39% 42
2016
Q1
$798K Hold
5,512
0.6% 65
2015
Q4
$725K Hold
5,512
0.57% 69
2015
Q3
$764K Hold
5,512
0.62% 58
2015
Q2
$857K Buy
5,512
+305
+6% +$49K 0.63% 48
2015
Q1
$799K Hold
5,207
0.6% 55
2014
Q4
$799K Buy
5,207
+1,498
+40% +$238K 0.64% 60
2014
Q3
$673K Buy
3,709
+1,935
+109% +$353K 0.55% 75
2014
Q2
$307K Hold
1,774
0.25% 92
2014
Q1
$326K Hold
1,774
0.27% 91
2013
Q4
$318K Hold
1,774
0.27% 93
2013
Q3
$314K Hold
1,774
0.29% 88
2013
Q2
$324K Buy
+1,774
New +$345K 0.32% 70

Other funds holding IBM

Weaver C. Barksdale & Associates's IBM Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its IBM (IBM) stake by 0.42% in Q4 2017, selling an estimated $4.94K and leaving 8,143 shares worth $1.19M. The position accounts for 1.26% of the portfolio, ranked #48.

Weaver C. Barksdale & Associates first reported a position in IBM in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.35M in Q1 2017. 1,975 funds tracked by Wall St. Rank hold IBM as of Q4 2017.

  • Weaver C. Barksdale & Associates held 8,143 shares of IBM worth $1.19M as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 34 IBM shares in Q4 2017, an estimated $4.94K.
  • IBM made up 1.26% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #48 holding.
  • Weaver C. Barksdale & Associates first reported a position in IBM in Q2 2013 and has held it in 19 quarters since.
  • Weaver C. Barksdale & Associates's IBM position peaked at $1.35M in Q1 2017.
  • 1,975 funds tracked by Wall St. Rank held IBM as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.